224
Participants
Start Date
July 25, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2026
RAP-219
RAP-219 tablets administered orally, once daily for 21 days
Placebo
Matching placebo tablets administered orally, once daily for 21 days
RECRUITING
Richmond Behavioral Associates, Staten Island
RECRUITING
CenExel - Gaithersburg, Gaithersburg
RECRUITING
New Hope Clinical Research, Charlotte
RECRUITING
CenExel - Decatur, Decatur
RECRUITING
United Research Institute, Hialeah
RECRUITING
Segal Trials - Miami Lakes Medical Research Early Phase, Inpatient & Outpatient Site, Miami Lakes
RECRUITING
CenExel - Hollywood, Hollywood
RECRUITING
Neuroscience Research Institute at Ambrosia, West Palm Beach
RECRUITING
NeuroBehavioral Hospitals of the Palm Beaches - South, Boynton Beach
RECRUITING
Pillar Clinical Research - Chicago, Chicago
RECRUITING
Arch Clinical Trials, St Louis
RECRUITING
Pillar Clinical Research - Little Rock, Little Rock
RECRUITING
Woodland International Research Group, Little Rock
RECRUITING
Woodland Research Northwest, Rogers
RECRUITING
Pillar Clinical Research - Richardson, Richardson
RECRUITING
HD Research - Memorial Hermann Village, Houston
RECRUITING
Community Clinical Research, Inc., Austin
RECRUITING
Collaborative Neuroscience Research - Los Alamitos, Los Alamitos
RECRUITING
Inland Psychiatric Medical Group - Chino, Chino
RECRUITING
Synergy Clinical Research Center - San Diego, Lemon Grove
RECRUITING
CNRI - San Diego, LLC, San Diego
RECRUITING
NRC Research Institute - Orange, Orange
Rapport Therapeutics Inc.
INDUSTRY